Wockhardt Plunges on U.S. Ban on Third Drug-Making Factory

Updated on
  • The India-based company had said it was addressing FDA issues
  • Ban affects drug products Wockhardt makes in Ankleshwar, India

Wockhardt Ltd. plunged the most in six months after its third drug-manufacturing plant in India was banned by the Food and Drug Administration from importing products into the U.S.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.